These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1536772)

  • 1. Hydroxychloroquine is useful in the management of atopic dermatitis.
    Smith KC
    Br J Dermatol; 1992 Jan; 126(1):93-4. PubMed ID: 1536772
    [No Abstract]   [Full Text] [Related]  

  • 2. Dramatic effect of hydroxychloroquine on lupus alopecia.
    Igari S; Yamamoto T
    J Dermatol; 2018 Feb; 45(2):194-197. PubMed ID: 29068087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Granulomatous periocular eruption].
    Moncourier M; Pralong P; Pinel N; Templier I; Leccia MT
    Ann Dermatol Venereol; 2017; 144(6-7):430-433. PubMed ID: 28410769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult-Onset Atopic Dermatitis: Fact or Fancy?
    Hanifin JM
    Dermatol Clin; 2017 Jul; 35(3):299-302. PubMed ID: 28577799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current clinical practice in atopic dermatitis.
    Odedra KM
    Nurs Stand; 2014 Aug; 28(49):45-51. PubMed ID: 25095959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging therapies for atopic dermatitis: The prostaglandin/leukotriene pathway.
    Yanes DA; Mosser-Goldfarb JL
    J Am Acad Dermatol; 2018 Mar; 78(3 Suppl 1):S71-S75. PubMed ID: 29248523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of severe atopic dermatitis with cysteinyl leukotriene receptor antagonist montelukast.
    Angelova-Fischer I; Tsankov N
    Acta Dermatovenerol Alp Pannonica Adriat; 2005 Sep; 14(3):115-9. PubMed ID: 16200338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atopic Dermatitis: The New Therapeutic Revolution in Dermatology.
    Torres T
    Acta Med Port; 2017 Oct; 30(10):669-670. PubMed ID: 29268058
    [No Abstract]   [Full Text] [Related]  

  • 9. [Transfer factor as specific immunomodulator in the treatment of moderate-severe atopic dermatitis].
    Flores Sandoval G; Gómez Vera J; Orea Solano M; López Tiro J; Serrano E; Rodríguez A; Rodríguez A; Estrada Parra S; Jiménez Saab N
    Rev Alerg Mex; 2005; 52(6):215-20. PubMed ID: 16568705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dynamics of interferon status in patients with atopic dermatitis during standard therapy combined with cycloferon].
    Gevorkian OV; Smirnova TD; Manakhova LS; Ospel'nikova TP
    Klin Med (Mosk); 2011; 89(4):54-5. PubMed ID: 21932566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of omalizumab for treatment of severe adult atopic dermatitis.
    Krathen RA; Hsu S
    J Am Acad Dermatol; 2005 Aug; 53(2):338-40. PubMed ID: 16021135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporin maintenance therapy for severe atopic dermatitis.
    Korstanje MJ; van de Staak WJ
    Acta Derm Venereol; 1991; 71(4):356-7. PubMed ID: 1681659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine A in atopic dermatitis.
    Gaig P; Alijotas J; López A; Valencia M; Cisteró A
    Allergol Immunopathol (Madr); 1993; 21(5):169-72. PubMed ID: 8160560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contact sensitivity in patients with recalcitrant atopic dermatitis.
    Tamagawa-Mineoka R; Masuda K; Ueda S; Nakamura N; Hotta E; Hattori J; Minamiyama R; Yamazaki A; Katoh N
    J Dermatol; 2015 Jul; 42(7):720-2. PubMed ID: 25808093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of difficult-to-treat atopic dermatitis.
    Arkwright PD; Motala C; Subramanian H; Spergel J; Schneider LC; Wollenberg A;
    J Allergy Clin Immunol Pract; 2013 Mar; 1(2):142-51. PubMed ID: 24565453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-corticosteroid adherence and itch severity influence perception of itch in atopic dermatitis.
    Takeuchi S; Oba J; Esaki H; Furue M
    J Dermatol; 2018 Feb; 45(2):158-164. PubMed ID: 29168215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long term management of childhood atopic dermatitis with calcineurin inhibitors].
    Thaçi D
    Hautarzt; 2003 May; 54(5):418-23. PubMed ID: 12719861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of pimecrolimus 1% cream in the long term management of atopic hand dermatitis. A double-blind RCT.
    Bauer A; Lange N; Matterne U; Meurer M; Braeutigam M; Diepgen TL
    J Dtsch Dermatol Ges; 2012 Jun; 10(6):426-33. PubMed ID: 22112014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical pimecrolimus: a review of its clinical potential in the management of atopic dermatitis.
    Wellington K; Jarvis B
    Drugs; 2002; 62(5):817-40. PubMed ID: 11929333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New treatments for atopic dermatitis].
    Bradley M; Wahlgren CF
    Lakartidningen; 2017 Nov; 114():. PubMed ID: 29292944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.